(Reuters) – Roche is considering selling its lung disease drug Esbriet, Bloomberg News reported on Monday citing people with knowledge of the matter.
The company did not immediately respond to a Reuters request for comment.
(Reporting by Sriparna Roy in Bengaluru)
